Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Matthews

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
The EMBO Journal|August 26, 1998
A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormoneT N Collingwood, R Wagner, C H Matthews, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
Blood Advances|May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Leukemia|August 1, 2014
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemiaD J DeAngelo, K E Stevenson, S E Dahlberg, et al.
Journal of Health Organization and Management|October 5, 2016
Leadership and management in UK medical school curriculaRichard Jefferies, Ibrahim H N Sheriff, Jacob H Matthews, et al.
American Journal of Hematology|June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Nature|October 12, 2000
An SNP map of human chromosome 22J C Mullikin, S E Hunt, C G Cole, et al.
Nature|April 2, 2004
The DNA sequence and analysis of human chromosome 13A Dunham, L H Matthews, J Burton, et al.
Nature|January 10, 2002
The DNA sequence and comparative analysis of human chromosome 20P Deloukas, L H Matthews, J Ashurst, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
The EMBO Journal|August 26, 1998
A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormoneT N Collingwood, R Wagner, C H Matthews, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
Blood Advances|May 4, 2022
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Leukemia|August 1, 2014
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemiaD J DeAngelo, K E Stevenson, S E Dahlberg, et al.
Journal of Health Organization and Management|October 5, 2016
Leadership and management in UK medical school curriculaRichard Jefferies, Ibrahim H N Sheriff, Jacob H Matthews, et al.
American Journal of Hematology|June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.
Nature|October 12, 2000
An SNP map of human chromosome 22J C Mullikin, S E Hunt, C G Cole, et al.
Nature|April 2, 2004
The DNA sequence and analysis of human chromosome 13A Dunham, L H Matthews, J Burton, et al.
Nature|January 10, 2002
The DNA sequence and comparative analysis of human chromosome 20P Deloukas, L H Matthews, J Ashurst, et al.
Pageof 35